 |
市場調查報告書
商品編碼
2058385
麻醉氣體市場：依產品種類、麻醉氣體種類、最終使用者及地區分類Anesthesia Gases Market, By Product Type, By Anesthesia Gases, By End User, By Geography |
||||||
價格
簡介目錄
預計到 2026 年，麻醉氣體市場規模將達到 21.105 億美元，到 2033 年將達到 27.106 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 3.9%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 21.105億美元 |
| 歷史數據時期： | 2020年至2024年 | 預測期： | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率： | 3.90% | 2033年市場規模預測： | 27.106億美元 |
麻醉氣體，也稱為吸入麻醉劑（如Isoflurane、SEVOFLURANE、DESFLURANE、氟烷和氧化亞氮），在手術全期作為術前鎮靜的主要治療方法以及作為靜脈（IV）麻醉劑（如咪達唑侖和Propofol）的輔助手段來維持麻醉。
市場動態
慢性病盛行率不斷上升、老年人口不斷成長、麻醉氣體需求不斷增加、手術中麻醉使用量不斷增加以及全球手術數量總體增加，預計這些因素將推動全球麻醉氣體市場在預測期內成長。
例如，2022年2月，Sedana Medical宣佈在德國推出Sedaconda（Isoflurane）。 Sedaconda（Isoflurane）透過Sedaconda ACD（麻醉劑節省裝置）醫療設備給藥，是目前唯一核准用於重症監護的吸入鎮靜療法。 Sedaconda於2021年7月獲得歐洲藥品管理局（DCP）的核准。
本次調查的主要特點
- 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
- 此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
- 本研究根據公司亮點、產品系列、主要特點、財務表現和策略等參數，創建了全球麻醉氣體市場主要公司的概況。
- 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
- 這份全球麻醉氣體市場報告旨在為行業內的各種相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 透過分析全球麻醉氣體市場的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。
目錄
第1章：研究目標與前提條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章：市場動態、監管與趨勢分析
- 市場動態
- 麻醉氣體需求或使用量增加
- 麻醉氣體的副作用
- 手術數量增加
- 影響分析
- 主要亮點
- 監管趨勢
- 產品上市及核准
- PEST分析
- 波特的分析
- 併購情景
第4章 全球麻醉氣體市場：依產品類型分類，2021-2033年
- 麻醉氣體
- 霧化器
第5章 全球麻醉氣體市場：依麻醉氣體類型分類，2021-2033年
- DESFLURANE
- SEVOFLURANE
- Isoflurane
- 氧化亞氮
- 其他麻醉氣體
第6章 全球麻醉氣體市場：依最終使用者分類，2021-2033年
- 醫院
- 門診手術中心
第7章 全球麻醉氣體市場：依地區分類，2021-2033年
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
- 非洲
- 南非
- 北非
- 中非
第8章 競爭情勢
- Baxter
- AbbVie Inc.
- Piramal Enterprises Ltd.
- Fresenius SE & Co. KgaA
- Dragerwerk AG & Co. KgaA
- GE Healthcare
- Mindray Medical International Limited
第9章
- 調查方法
- 關於本公司
簡介目錄
Product Code: CMI5499
Anesthesia Gases Market is estimated to be valued at USD 2,110.5 Mn in 2026 and is expected to reach USD 2,710.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 3.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2,110.5 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 3.90% | 2033 Value Projection: | USD 2,710.6 Mn |
Anesthetic gases (isoflurane, sevoflurane, desflurane, halothane, and nitrous oxide, among others), also known as inhaled anesthetics, are administered as a primary therapy for preoperative sedation and adjunctive anesthesia maintenance to intravenous (IV) anesthetic agents (such as midazolam and propofol) in the perioperative setting.
Market Dynamics
Increase in prevalence of chronic diseases, increase in geriatric (aging) population, rise in demand for anesthesia gases, increase in use of anesthesia during surgeries, and rise in number of surgical procedures around the world are major factors expected to propel growth of the global anesthesia gases market during the forecast period.
For instance, in February 2022, Sedana Medical announced the launch of Sedaconda (isoflurane) in Germany. Sedaconda (isoflurane), delivered via medical device Sedaconda ACD (Anaesthetic Conserving Device), is the only approved inhaled sedation therapy for use during intensive care. Sedaconda received European DCP approval in July 2021.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global anesthesia gases market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Baxter, AbbVie Inc., Piramal Enterprises Ltd., Fresenius SE & Co. KgaA, Dragerwerk AG & Co. KgaA, GE Healthcare, and Mindray Medical International Limited, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global anesthesia gases market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global anesthesia gases market.
Market Segmentation
- By Product Type (Revenue, USD Mn, 2021-2033)
- Anesthesia Gases
- Vaporizer Devices
- By Anesthesia Gases (Revenue, USD Mn, 2021-2033)
- Desflurane
- Sevoflurane
- Isoflurane
- Nitrous Oxide
- Other Anesthesia Gases
- By End User (Revenue, USD Mn, 2021-2033)
- Hospital
- Ambulatory Surgical Centers
- By Region (Revenue, USD Mn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Competitive Landscape
- Baxter
- AbbVie Inc.
- Piramal Enterprises Ltd.
- Fresenius SE & Co. KgaA
- Dragerwerk AG & Co. KgaA
- GE Healthcare
- Mindray Medical International Limited
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Anesthesia Gases
- Market Snapshot, By End User
- Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Increase in demand for or use of anesthesia gases
- Side effects of anesthesia gases
- Increase in number of surgical procedures
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Anesthesia Gases Market, By Product Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Anesthesia Gases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Vaporizer Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Anesthesia Gases Market, By Anesthesia Gases, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Desflurane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Sevoflurane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Isoflurane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Nitrous Oxide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Other Anesthesia Gases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Anesthesia Gases Market, By End User, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Anesthesia Gases Market, By Geography, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Anesthesia Gases, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Anesthesia Gases, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Anesthesia Gases, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Anesthesia Gases, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021-2033, (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Anesthesia Gases, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Anesthesia Gases, 2021-2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Baxter
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Piramal Enterprises Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fresenius SE & Co. KgaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Dragerwerk AG & Co. KgaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GE Healthcare
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mindray Medical International Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
